Senator Jacky Rosen Under Investigation for False Financial Disclosures

Senator Jacky Rosen (D., Nev.) has come under scrutiny for filing inaccurate financial disclosures throughout her first term in the Senate, as revealed by her attorney in a notice to the Senate on July 26. Rosen failed to disclose her role as trustee of the Larry and Jacklyn Rosen Family Trust, which reportedly held assets worth up to $14.6 million in 2022. This omission raises questions about her financial transparency, particularly as she has publicly criticized pharmaceutical companies while holding stock in major firms like Pfizer through the trust. Rosen's claims regarding her lack of control over the trust's stock trades are now being questioned, given her position as trustee. This follows a previous controversy in 2023 when she was accused of violating the STOCK Act by failing to disclose a trade made by her family trust. A spokesperson for Rosen had previously dismissed Republican criticisms, stating that the trade was an automatic exchange beyond the family's control. However, the recent revelations about her trustee role complicate her defense. Craig Holman, a lobbyist at Public Citizen, noted that the errors in Rosen's disclosures are significant. While senators face a $200 penalty for late filings, Holman suggested that if the inaccuracies were unintentional, it is unlikely Rosen would face substantial fines from the Senate Ethics Committee. The committee has not commented on the matter. In addition to her financial disclosure issues, Rosen has also reportedly fallen behind on property tax payments for her $1 million home in Henderson, Nevada, further complicating her financial standing.